USPTO issues Notice of Allowance to Neurana Pharmaceuticals for two new tolperisone patents Read more
Optibrium and Imperial College Collaborate for Drug Development for Neglected Diseases as part of project with DNDi Read more
US FDA ODAC recommends the approval of Pizer’s epoetin alfa biosimilar across all indications Read more